Three-drug attack aims to make inoperable stomach cancer operable
NCT ID NCT05177068
Summary
This study is testing a combination of three drugs to see if they can shrink advanced stomach tumors enough for surgeons to remove them completely. It is for adults with stage IV gastric cancer that cannot be operated on initially. The goal is to control the disease by converting it to a surgically removable state.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henan Tumor Hospital
Zhengzhou, Henan, 450000, China
Conditions
Explore the condition pages connected to this study.